About the Authors
- Gergès Rizkallah
-
Affiliations International Center for Research in Infectiology, Retroviral Oncogenesis laboratory, INSERM U1111 –Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France, Equipe labellisée “Ligue Nationale Contre le Cancer”, Lyon, France
- Sandrine Alais
-
Affiliations International Center for Research in Infectiology, Retroviral Oncogenesis laboratory, INSERM U1111 –Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France, Equipe labellisée “Ligue Nationale Contre le Cancer”, Lyon, France
- Nicolas Futsch
-
Affiliations International Center for Research in Infectiology, Retroviral Oncogenesis laboratory, INSERM U1111 –Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France, Equipe labellisée “Ligue Nationale Contre le Cancer”, Lyon, France
- Yuetsu Tanaka
-
Affiliation Department of Immunology, Graduate School of Medicine, University of the Ryukyus, Uehara 207, Nishihara-cho, Okinawa, Japan
- Chloé Journo
-
Affiliations International Center for Research in Infectiology, Retroviral Oncogenesis laboratory, INSERM U1111 –Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France, Equipe labellisée “Ligue Nationale Contre le Cancer”, Lyon, France
- Renaud Mahieux
-
Affiliations International Center for Research in Infectiology, Retroviral Oncogenesis laboratory, INSERM U1111 –Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France, Equipe labellisée “Ligue Nationale Contre le Cancer”, Lyon, France
- Hélène Dutartre
-
* E-mail: helene.dutartre@ens-lyon.fr
Affiliations International Center for Research in Infectiology, Retroviral Oncogenesis laboratory, INSERM U1111 –Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France, Equipe labellisée “Ligue Nationale Contre le Cancer”, Lyon, France
Competing Interests
The authors have declared that no competing of interests exit.
Author Contributions
Conceptualization: GR RM HD. Formal analysis: GR HD. Funding acquisition: CJ RM HD. Investigation: GR NF SA CJ RM HD. Methodology: GR NF SA. Project administration: RM HD. Resources: YT. Supervision: RM HD. Validation: RM HD. Visualization: GR HD. Writing – original draft: GR HD. Writing – review & editing: GR NF SA CJ YT RM HD.